Beyond Medical Technologies Inc (CSE:DOCT) (FRA:7FM3) said that telehealth company Kayan Health has inked a Memorandum of Understanding (MoU) with Predictiv Care Inc, a personalized genomics tech platform aimed at empowering healthcare professionals with predictive medicine.
On January 14, 2021, Beyond Medical announced that it had signed a letter of intent to acquire Kayan Health, which has an artificial intelligence (AI) powered health communications platform to help doctors monitor patients remotely.
The Vancouver-based group said the partnership between Kayan Health and Predictiv will provide “a personalized approach to predictive medicine and will significantly increase the patient-physician relationship.”
READ: Micron Waste Technologies to change name to Beyond Medical Technologies
Under the terms of the MOU, Kayan Health and Predictiv will collaborate to integrate their technologies to deliver a range of DNA-Based AI-powered services ensuring that clinics and healthcare providers are better equipped to support their patients.
In addition to Kayan’s AI-driven patient triaging platform, Predictiv will enable Kayan to offer a pre-diagnosis based on the patient’s symptoms combined with their personal genome. This will provide the opportunity to identify at-risk patients early on and increase the rates of successful treatments.
“It will also enable genetics-based vital monitoring through wearable technology and medical-grade diagnostic devices,” noted the company.
Moreover, Kayan Health’s telehealth platform will help patients with the early detection and diagnosis of more than 16,000 diseases, give them key information about their health, and help streamline their communication with their doctor.
“Our goal is to empower healthcare providers and help them be more proactive and streamlined in their delivery of personalized care to their patients through innovative healthcare technologies. Our partnership with Predictiv is a key milestone in our journey in achieving that goal,” Kayan Health CEO Ahmad Al-Hidiq said in a statement.
“By providing healthcare professionals access to not just their patients’ vital data, but also combining that with their personal genome would enable them to access insight they would have not been able to easily access before ensuring their patients receive truly personalized care.”
Predictiv CEO Sajung Yun said the “exciting collaboration” with Kayan Health will enable its partners and users to go “one step further by bringing them an all-in-one platform that integrates the tools they need to predict, prevent and monitor the health of their patients.”
“This partnership will also make it the most complete and advanced solution on the market for predictive and personalized medicine. Our objective has always been to save one million lives every year,” added Yun.
Beyond Medical is an industrial/technology company with a manufacturing facility in Delta, British Columbia. It is developing its Organivore and Pharmavore waste digesters using its proprietary technology. The group’s subsidiary Micron Technologies is manufacturing medical-grade facemasks compliant with ASTM F2100 standards.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive